Loading clinical trials...

Rapid Turnaround, Home-based Saliva Testing for COVID-19 | Clinical Trials | Clareo Health

COMPLETEDNA

Rapid Turnaround, Home-based Saliva Testing for COVID-19

NCT04568122•Stanford University

Summary

The aim of the study is to demonstrate the feasibility and validity of a saliva based home surveillance monitoring test for SARS-CoV-2 infection. Participants will be asked to carry out as many tests as are included in the bag they are provided, on a daily basis until they are used up.

Eligibility

Age

2 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Hospitalized patients
•* Hospitalized at Stanford Health Care for COVID-related complications and tested positive for SARS-CoV-2 with a PCR-based test
•* Able to understand and consent to study and with a clinical trajectory likely to be consistent with multi-day participation
•High-risk/positive population
•* Seeking testing for suspected COVID or a participant in a study of COVID-positive outpatients
•* Own an internet-enabled phone or device capable of loading web pages, receiving text messages, and taking/uploading photos.
•* Willing to participate in the study for 6 months
•Low-risk population
•* Own an internet-enabled phone or device capable of loading web pages, receiving text messages, and taking/uploading photos.
•* Willing to participate in the study for 6 months
+7 more criteria

Exclusion Criteria

•All participants:
•* Participants with salivary gland dysfunction (including patients with Sjogren's disease or those with xerostomia associated with lupus or rheumatoid arthritis)

Locations (2)

SHC Valley Care

Pleasanton, California, United States

Stanford University

Stanford, California, United States

Key Dates

Start Date

November 20, 2020

Primary Completion Date

December 10, 2022

Completion Date

December 10, 2022

Last Updated

January 10, 2024

Enrollment

1,277

ACTUAL participants

Conditions

Covid19

Interventions

Saliva test kit

DEVICE

The Effect of the Covid-19 Pandemic Among Operated Patients

NCT04525716

Covid19Surgery

View study

RECRUITINGPHASE3

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

NCT03188796

Critical IllnessVitamin D Deficiency+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 10, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Rapid Turnaround, Home-based Saliva Testing for COVID-19

Inclusion Criteria

Exclusion Criteria

The Effect of the Covid-19 Pandemic Among Operated Patients

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

Covid-19 and Influenza Oral Vaccine Study

Conversations You Want About Corona Virus Disease (COVID-19)

Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy